An infant with ETV6‐NTRK3 fusion‐positive congenital infantile fibrosarcoma and delayed response to conventional chemotherapy avoiding the need for TRK inhibition. Issue 10 (3rd August 2020) - Vedi, Aditi; Holland, Katherine; Cross, Justin; Muthusamy, Brinda; Behjati, Sam; Hook, C. Elizabeth; Murray, Matthew J.